- Home
- FNWB vs IMMX Comparison
FNWB vs IMMX Comparison
Compare FNWB & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- IMMX
- Stock Information
- Founded
- FNWB 1923
- IMMX 2014
- Country
- FNWB United States
- IMMX United States
- Employees
- FNWB N/A
- IMMX N/A
- Industry
- FNWB Banks
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- FNWB Finance
- IMMX Health Care
- Exchange
- FNWB Nasdaq
- IMMX Nasdaq
- Market Cap
- FNWB 69.1M
- IMMX 82.6M
- IPO Year
- FNWB 2015
- IMMX 2021
- Fundamental
- Price
- FNWB $8.90
- IMMX $3.33
- Analyst Decision
- FNWB Hold
- IMMX Strong Buy
- Analyst Count
- FNWB 1
- IMMX 1
- Target Price
- FNWB $12.00
- IMMX $8.00
- AVG Volume (30 Days)
- FNWB 12.4K
- IMMX 800.1K
- Earning Date
- FNWB 10-27-2025
- IMMX 11-07-2025
- Dividend Yield
- FNWB 2.32%
- IMMX N/A
- EPS Growth
- FNWB N/A
- IMMX N/A
- EPS
- FNWB N/A
- IMMX N/A
- Revenue
- FNWB $59,854,000.00
- IMMX N/A
- Revenue This Year
- FNWB $33.26
- IMMX N/A
- Revenue Next Year
- FNWB $10.68
- IMMX N/A
- P/E Ratio
- FNWB N/A
- IMMX N/A
- Revenue Growth
- FNWB 17.90
- IMMX N/A
- 52 Week Low
- FNWB $6.05
- IMMX $1.34
- 52 Week High
- FNWB $12.10
- IMMX $4.05
- Technical
- Relative Strength Index (RSI)
- FNWB 63.85
- IMMX 57.17
- Support Level
- FNWB $8.91
- IMMX $2.31
- Resistance Level
- FNWB $9.50
- IMMX $4.05
- Average True Range (ATR)
- FNWB 0.26
- IMMX 0.37
- MACD
- FNWB 0.08
- IMMX 0.02
- Stochastic Oscillator
- FNWB 65.52
- IMMX 50.00
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.